Advertisement
News
Subscribe to MDT Magazine News

Third trimester group B streptococcus test doesn't accurately predict presence during labor

February 10, 2011 9:35 pm | by EurekAlert | Comments

(Society for Maternal-Fetal Medicine) In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Francisco, researchers will present findings that show that many women are having different test results for Group B...

TOPICS:

Study finds even with fetal lung maturity, babies delivered prior to 39 weeks are at risk

February 10, 2011 9:32 pm | by EurekAlert | Comments

(Society for Maternal-Fetal Medicine) In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, the Pregnancy Meeting, in San Francisco, researchers will present findings that show that despite fetal pulmonary maturity, babies delivered at...

TOPICS:

Study finds preterm birth clinic attendence leads to major reduction in infant disability

February 10, 2011 9:31 pm | by EurekAlert | Comments

(Society for Maternal-Fetal Medicine) In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Francisco, researchers will present findings that show that when women at high risk for preterm birth participated in a preterm...

TOPICS:
Advertisement

Sensonor announces the SP400, an integrated wireless low-power pressure sensor

February 10, 2011 7:35 pm | by I-Micronews | Comments

The SP400-series is a high accuracy wireless digital absolute pressure sensor. SP400 is a fully calibrated and compensated sensor with an embedded RISC micro controller. It is available in 4 pressure ranges from 150kPa(22psi) to 2000kPa(290psi).

Extensive research demonstrates fructose does not increase food intake or impact weight

February 10, 2011 5:37 pm | by EurekAlert | Comments

(Kellen Communications) A new comprehensive review, recently published in Critical Reviews in Food Science and Nutrition, concludes that fructose does not increase food intake or impact body weight or blood triglycerides in overweight or obese individuals. These findings support...

TOPICS:

New online tool predicts probability of death from stroke

February 10, 2011 5:37 pm | by EurekAlert | Comments

(St. Michael's Hospital) Researchers at St. Michael's Hospital and the Institute for Clinical and Evaluative Sciences in Toronto have developed a new tool that will help doctors predict the probability of death in patients after an ischemic stroke.

TOPICS:

Renaissance Surgical Arts at Newport Harbor Announces Single-Dose Radiation Treatment Alternative for Women with Early Breast Cancer

February 10, 2011 5:36 pm | by Bio-Medicine.Org | Comments

COSTA MESA, Calif., Feb. 10, 2011 /- Renaissance Surgical Arts at Newport Harbor announced today that it is the first outpatient surgery center in the Western United States to offer intraoperative radiotherapy (IORT) using the INTRABEAM® System – the only device used in the...

TOPICS:

Seniors in Ohio Report Problems With Access to Home Medical Equipment and Services Under Controversial Medicare Bidding System

February 10, 2011 5:34 pm | by Bio-Medicine.Org | Comments

CLEVELAND, Feb. 10, 2011 /PRNewswire-USNewswire/ -- Medicare beneficiaries are reporting problems receiving medically required home medical equipment and services following the January 1, 2011 implementation of Medicare's "competitive" bidding program in Cleveland and Cincinnati. The...

TOPICS:
Advertisement

Mafraq Hospital Becomes First in United Arab Emirates to Deploy Masimo rainbow SET Pulse CO-Oximetry for State-of-the-Art Noninvasive Patient Monitoring

February 10, 2011 5:33 pm | by Bio-Medicine.Org | Comments

IRVINE, Calif. and DUBAI, United Arab Emirates, Feb. 10, 2011 /- Mafraq Hospital and Masimo (Nasdaq: MASI ) jointly announced the hospital-wide conversion of Mafraq Hospital to Masimo rainbow® SET Pulse CO-Oximetry™ technology for advanced noninvasive patient monitoring...

TOPICS:

Neurocrine rises to 4Q profit on licensing fees

February 10, 2011 4:45 pm | by The Associated Press | Comments

Biotechnology company Neurocrine Biosciences Inc. said Thursday it rose to a profit in the fourth quarter from a year-ago loss due to higher research and development and licensing payments.The company earned $2.5 million, or 4 cents per share, compared with a loss of $7.9 million, or 20 cents...

President and CEO of Visiting Nurse Service of New York to Speak at ASU in March

February 10, 2011 10:35 am | by Arizona State University | Comments

The ASU College of Nursing & Health Innovation is pleased to welcome visiting scholar and national healthcare policy expert, Carol Raphael.read more

TOPICS:

Information on Metal-on-Metal Hip Implants

February 10, 2011 10:30 am | by U.S. Food & Drug Administration | Comments

Hip joint deterioration can lead to symptoms such as pain, stiffness or difficulty walking. When symptoms do not respond to conservative treatment, patients may be advised to undergo total hip replacement or hip resurfacing...

TOPICS:

Milberg LLP and The Weiser Law Firm, P.C. Announce Filing of Amended Shareholder Complaint Against Beckman Coulter, Inc. (BEC)

February 10, 2011 9:45 am | by The Associated Press | Comments

Milberg LLP and The Weiser Law Firm, P.C. today announced that on February 9, 2011, the firms filed an amended shareholder derivative and class action complaint against Beckman Coulter, Inc. ("Beckman Coulter" or the "Company") (NYSE: BEC) and its Board of Directors, amplifying the...

Electromed 2Q profit rises on SmartVest sales

February 10, 2011 9:45 am | by The Associated Press | Comments

Medical device maker Electromed Inc. said Thursday its net income climbed in the fiscal second quarter on better sales of its SmartVest Airway Clearance System.Electromed said its profit grew to $292,000, or 4 cents per share, in the three months ended Dec. 31. A year earlier it earned $35,000,...

EMD Serono opens $65M Billerica facility

February 10, 2011 9:39 am | by Mass High Tech: The Journal of New England Technology | Comments

EMD Serono Inc. today said that its new, $65 million research facility in Billerica demonstrates its commitment to growing the life sciences sector in Massachusetts.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading